References
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease [Internet]. 2017. Available from: http://goldcopd.org/
- Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int. J. Chron. Obstruct. Pulmon. Dis. [Internet]. 2009[cited 2017 Jun 7];4:381–390. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19888356. doi:10.2147/COPD.S3391. PMID:19888356.
- Bateman ED, Rabe KF, Calverley PMA, Goehring UM, Brose M, Bredenbröker D, Fabbri LM. Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur. Respir. J. [Internet]. 2011 Sep [cited 2014 Sep 17];38(3):553–560. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21737553. doi:10.1183/09031936.00178710. PMID:21737553.
- Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int. J. Cancer [Internet]. 2009;125(2):398–405. Available from: http://www3.interscience.wiley.com/cgi-bin/fulltext/121655446/PDFSTART. doi:10.1002/ijc.24287. PMID:19365835.
- Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir. Med. [Internet]. 2013 Oct[cited 2017 Jun 7];107(10):1481–1490. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0954611113001340. doi:10.1016/j.rmed.2013.04.005. PMID:23643487.
- Fink JB, Colice GL, Hodder R. Inhaler devices for patients with COPD. COPD [Internet]. 2013 Aug 28 [cited 2017 Jun 7];10(4):523–535. Available from: http://www.tandfonline.com/doi/full/10.3109/15412555.2012.761960. doi:10.3109/15412555.2012.761960. PMID:23537191.
- GlaxoSmithKline. ANORO ELLIPTA prescribing information [Internet]. 2017. Available from: www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Anoro_Ellipta/pdf/ANORO-ELLIPTA-PI-MG.PDF
- Boehringer-Ingelheim. SPIRIVA HANDIHALER prescribing information [Internet]. 2016. Available from: http://docs.boehringer-ingelheim.com/PrescribingInformation/PIs/Spiriva/Spiriva.pdf
- Riley JH, Tabberer M, Richard N, Donald A, Church A, Harris SS. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials. Int J Chron Obstruct Pulmon Dis [Internet]. 2016 Aug [cited 2017 Jul 5];11:1873–80. Available from: https://www.dovepress.com/correct-usage-ease-of-use-and-preference-of-two-dry-powder-inhalers-in-peer-reviewed-article-COPD. doi:10.2147/COPD.S109121. PMID:27578968.
- van der Palen J, Thomas M, Chrystyn H, Sharma RK, van der Valk PD, Goosens M, Wilkinson T, Stonham C, Chauhan AJ, Imber V, et al. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: Comparison of ELLIPTA with other inhaler devices. NPJ Prim care Respir Med [Internet]. 2016 Nov 24 [cited 2017 Jun 7];26(1):16079. Available from: http://www.nature.com/articles/npjpcrm201679. doi:10.1038/npjpcrm.2016.79. PMID:27883002.
- Melani AS, Canessa P, Coloretti I, DeAngelis G, DeTullio R, Del Donno M, Giacobbe R, Scarlato I, Serafini A, Barbato N, et al. Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use. Respir Med [Internet]. 2012 May [cited 2017 Jun 7];106(5):668–676. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22277996. doi:10.1016/j.rmed.2011.11.016. PMID:22277996.
- Melani AS. Inhalatory therapy training: a priority challenge for the physician. Acta Biomed [Internet]. 2007 Dec [cited 2017 Jun 7];78(3):233–245. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18330086
- Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev [Internet]. 2005 [cited 2017 Jun 7];14:109–116. Available from: http://err.ersjournals.com/content/errev/14/96/109.full.pdf. doi:10.1183/09059180.05.00009606.